Pharmacology
 |
|
8 november 2018 17:00:18 |
| Comment on `Proton Pump Inhibitor Use and Risk of Developing Alzheimer`s Disease or Vascular Dementia: A Case-Control Analysis` (Drug Safety) |
|
Tweet |
| 124 viewsCategory: Pharmacology |
 Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience (Drug Safety)Correction to: Abstracts of the 18th ISoP Annual Meeting `Pharmacovigilance without borders` Geneva, Switzerland, 11-14 November, 2018 (Drug Safety) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
